Market Newsdesk

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

• Independent Bank Corporation (NASDAQ: 
  
  IBCP
  
  ) related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.

Click here for more information

https://monteverdelaw.com/case/independent-bank-corporation/

. It is free and there is no cost or obligation to you.

• HCB Financial Corp. (OTCPK: 
  
  HCBN
  
  )  related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.

Click here for more information

https://monteverdelaw.com/case/hcb-financial-corp/

. It is free and there is no cost or obligation to you.

• Talkspace, Inc. (NASDAQ: 
  
  TALK
  
  ) related to its sale to Universal Health Services, Inc. Under the terms of the proposed transaction, Talkspace shareholders will be entitled to receive $5.25 per share in cash.

Click here for more information

https://monteverdelaw.com/case/talkspace-inc/

. It is free and there is no cost or obligation to you.

• UniFirst Corporation (NYSE: 
  
  UNF
  
  ) related to its sale to Cintas Corporation. Under the terms of the proposed transaction, UniFirst shareholders will be entitled to receive $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share.

Click here for more info

https://monteverdelaw.com/case/unifirst-corporation/

.
It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

1. Do you file class actions and go to Court?
2. When was the last time you recovered money for shareholders?
3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) — HeartSciences Inc.  (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), will present at Investor Summit Group Virtual Conference, March 25, 2026 at 12:30 pm ET.

Hosted by Investor Summit Group, a premier platform connecting microcap companies with leading investors, the event provides a highly efficient forum for emerging growth companies to engage directly with institutional investors, family offices, and high-net-worth individuals.

Event Details:

• Conference: Investor Summit Group Virtual Conference
• Format: Virtual Presentations & One-on-One Investor Meetings
• Presentation Date: March 25, 2026
• Presentation Time: 12:30 pm to 1:00 pm ET
• Registration:
  HeartSciences Investor Summit
  

During the conference, HeartSciences’ CEO, Andrew Simpson, will deliver a corporate presentation outlining its business strategy, recent milestones, and near-term growth catalysts. The Company will also participate in a series of virtual one-on-one meetings with qualified investors on Thursday, March 26. Investors interested in scheduling a one-on-one meeting with CEO Andrew Simpson may do so by visiting HeartSciences Investor Summit for registration details.

“Our participation in the Investor Summit Group conference reflects our commitment to expanding our investor base and increasing visibility within the capital markets,” said CEO Andrew Simpson. “As we continue to execute on our growth strategy, this platform allows us to communicate our value proposition to investors.”

About HeartSciences
HeartSciences is a healthcare information technology (“HIT”) company advancing the use of ECG/EKGs through the integration of artificial intelligence (“AI”). The Company’s MyoVista Insights platform is a device-agnostic, next-generation ECG management system designed to improve clinical efficiency and decision-making. Its MyoVista wavECG device is designed to deliver conventional ECG functionality while supporting on-device AI-enabled solutions

For more information, please visit: https://www.heartsciences.com. X: @HeartSciences

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company’s future financial and operating performance. All statements, other than statements of historical facts, included herein are “forward-looking statements” including, among other things, statements about HeartSciences’ beliefs and expectations. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company’s control. The expectations reflected in these forward-looking statements involve significant assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences’ Annual Report on Form 10-K for the fiscal year ended April 30, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 24, 2025, HeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2025 filed with the SEC on September 11, 2025, HeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2025 filed with the SEC on December 15, 2025, HeartSciences’ Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026 filed with the SEC on March 16, 2026, and in HeartSciences’ other filings with the SEC at www.sec.gov. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Investor Relations:

Integrous Communications
Mark Komonoski, Partner
Phone: 877 255 8483
Email: [email protected]

Media Contact:

HeartSciences
Gene Gephart
Phone: +1 682 244 2578 Ext. 2024
Email: [email protected]

VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — Equity-Insider.com — The most valuable technology companies of the next decade will not be the ones that stay in their lane. They will be the ones that take defense-grade capabilities — AI, autonomy, sensing, signal processing — and deploy them into the trillion-dollar industries where legacy methods still dominate.

That thesis is playing out in real time across the defence-industrial complex. Palantir Technologies (NYSE: PLTR) just had 75 separate U.S. Army contracts consolidated into a single $10 billion enterprise agreement, reflecting the military’s shift from buying individual tools to licensing entire AI-driven platforms. Palantir’s stock has gained more than 80% over the past year as investors price in the expansion of its Gotham and Foundry platforms from defense into commercial and industrial verticals.

Kratos Defense (NASDAQ: KTOS) rallied 31% over six months on a string of contract wins — including a $61 million Navy aerial target production deal, a $7 million counter-UAS system contract, and hypersonic vehicle testing awards — proving that autonomous systems built for defense are generating accelerating revenue as the DOD budget for AI reaches $66 billion.

The pattern is clear: defence AI companies that can cross into adjacent industrial markets carry a valuation premium the market is willing to pay for.

Oceaneering International (NYSE: OII), with 60 years of deep-sea expertise, operates one of the largest global fleets of subsea robotics and autonomous underwater vehicles, providing AI-driven inspection, survey, and maintenance capabilities across offshore energy, defense, and aerospace markets. The company reported $2.8 billion in 2025 revenue with operating income up 24% year over year.

SoundHound AI (NASDAQ: SOUN) saw revenue jump 68% year over year by taking voice AI originally built for automotive and applying it across restaurants, healthcare, and financial services. The companies that are building multi-industry platforms from defence-grade cores are the ones drawing institutional capital.

And now, an AI sensing company originally built for defense and security applications has taken its most significant step into a new vertical.

VisionWave Holdings, Inc. (Nasdaq: VWAV) announced today that it has entered into a Letter of Engagement with the National Oil Company of Liberia (NOCAL) relating to offshore petroleum Blocks LB-4 and LB-5 in the Liberia Basin. The LOE provides VisionWave with an exclusive eight-month pathway to advance toward a potential Production Sharing Contract with the Government of Liberia, subject to prequalification, regulatory approvals, and legislative ratification.

This is not a pivot away from defence. It is a deployment of the same core technology into a market where the economics of even incremental improvement are enormous. Offshore exploration is one of the most capital-intensive industries on Earth, and it relies heavily on legacy seismic and geophysical methods that have changed relatively little in decades.

VisionWave intends to evaluate its proprietary RF-based sensing and imaging technologies as part of the exploration workflow alongside traditional methods. The company believes RF approaches may provide additional signal pathways in complex subsurface environments, potentially enabling improved detection of challenging geological formations, enhanced subsurface modeling, and more efficient identification of undersea resources.

“This engagement represents a strategic step in expanding VisionWave’s technology platforms into large-scale global industries,” said Douglas Davis, CEO and Executive Chairman. “We believe that combining conventional exploration methodologies with advanced RF-based sensing technologies may introduce new capabilities into offshore resource identification.”

Key terms include exclusive rights to pursue both blocks for eight months, an initial signing bonus of $300,000 per block ($600,000 total, refundable under specified conditions), and a defined pathway toward PSC execution. The company continues to prioritize its core defence and security programs while pursuing this strategic expansion.

The defence technology companies that will define the next decade are the ones deploying AI and advanced sensing into trillion-dollar industries where legacy methods still dominate.

VisionWave Holdings (Nasdaq: VWAV) just secured an exclusive pathway to bring defence-grade RF sensing technology to offshore energy exploration in West Africa — and the market hasn’t caught up to what that means.

For more information on VisionWave Holdings, Inc. (Nasdaq: VWAV), visit Equity-Insider.com

Read this and more news for VisionWave at: Equity-Insider.com

Article Source: https://equity-insider.com/vwav-profile/

CONTACT:

EQUITY INSIDER
[email protected]
(604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is owned by Market IQ Media Group, Inc. (“MIQ”). This article is being distributed for MIQ, who has been paid a fee for VisionWave Holdings, Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares of VisionWave Holdings, Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ owns shares of VisionWave Holdings, Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of VisionWave Holdings, Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by VisionWave Holdings, Inc.; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. This publication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and beliefs and involve risks and uncertainties that could cause actual results to differ materially from those described. Forward-looking statements in this document are subject to risks and uncertainties, including technological, regulatory, market, and geopolitical factors, which may cause actual results to differ materially. VisionWave Holdings, Inc. makes no representations or warranties as to the accuracy of third-party projections or market data cited herein.

WILMINGTON, Mass., March 24, 2026 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, is proud to have been named to Fast Company’s list of the World’s Most Innovative Companies of 2026. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations.

Symbotic earned the #9 ranking in the Robotics & Engineering category. This marks the second time it has been recognized as part of Fast Company’s Most Innovative Companies list.

“We’re honored to once again be recognized by Fast Company as one of the world’s most innovative companies,” said Rick Cohen, Chairman and Chief Executive Officer of Symbotic. “This speaks to the creativity and capabilities of our team and the unique platform we’ve built to help customers transform operations with intelligent systems and reimagine what’s possible across the supply chain.”

Symbotic’s technology combines advanced robotics, artificial intelligence, and software to optimize warehouse operations for some of the world’s largest retailers, wholesalers, and healthcare companies. Its high-density, autonomous, end-to-end system is reinventing warehouse automation and helping customers streamline product movement, optimize inventory, improve flexibility, and reduce costs.

The World’s Most Innovative Companies is Fast Company’s hallmark franchise and one of its most anticipated editorial efforts of the year. To determine honorees, Fast Company’s editors and writers review companies driving progress around the world and across industries, evaluating thousands of submissions through a competitive application process. The result is a globe-spanning guide to innovation today, from early-stage startups to some of the most valuable companies in the world.

“Our list of the Most Innovative Companies is about spotlighting organizations that don’t just adapt to change – they drive it,” said Brendan Vaughan, editor-in-chief of Fast Company. “The companies we honor this year are redefining what leadership looks like in 2026, pairing bold ideas with measurable impact and turning breakthrough innovation into real-world value. They are setting the pace for their industries and offering a blueprint for what sustained innovation can achieve.”

The full list of Fast Company’s Most Innovative Companies honorees can now be found at fastcompany.com. It will also be available on newsstands beginning March 31, 2026.

ABOUT SYMBOTIC

Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today’s complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.

ABOUT FAST COMPANY

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.

MEDIA CONTACT

Matt Buckley
Vice President, Communications
[email protected]

INVESTOR RELATIONS CONTACT

Charlie Anderson
Vice President, Investor Relations & Corporate Development
[email protected]

• IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.
• IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.
• IM8’s Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower’s recommended foundational daily supplements in members’ personalized health protocols.

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced a strategic partnership with Superpower, the preventive health platform backed by over $40 million in venture funding. The first-of-its-kind partnership connects clinical-grade supplementation with comprehensive blood diagnostics, enabling an optimized testing loop to provide consumers with measurable proof behind supplement efficacy.

IM8 and Superpower are teaming up to address a fundamental gap within the wellness industry: most people who take supplements have no way to measure whether they’re working; meanwhile, most blood testing platforms surface hundreds of data points, but leave consumers to navigate a fragmented, low-quality supplement market on their own. Neither side has been able to close the gap alone – until now.

Under the partnership, IM8 — co-founded by David Beckham — will integrate Superpower’s annual blood testing membership into the IM8 customer journey at exclusive pricing, while Superpower will integrate IM8’s Daily Ultimate Essentials into its personalized health protocols as a featured foundational nutritional ritual, available to all members on its supplement marketplace at a preferred rate. The partnership reflects a broader shift in how consumers approach their health; from reactive treatment to proactive optimization, powered by personal data.

“I co-founded IM8 with David Beckham to fix the quality problem in supplements — clinical-grade formulations, full transparency, no shortcuts,” said Danny Yeung, CEO of Prenetics and IM8. “But formulation was only half the equation. The other half was measurement. With Superpower, an IM8 customer can now test 100+ biomarkers, take our products for 90 days, retest, and see measurable results. That’s not a marketing claim. That’s proof. No other supplement brand on the market can offer that.”

[1] IM8 subscribers on the 90-day Daily Ultimate Essentials plan will be able to redeem a Superpower membership for $49 per year, which translates to a 75% saving on Superpower’s standard $199 annual price. Monthly IM8 subscribers will gain access to the Superpower membership for $99 per year, a 50% saving. Both tiers include Superpower’s complete offering: its comprehensive initial 100+ biomarker test, an AI health layer grounded in each individual’s real data – not generic advice, and 24/7 access to its concierge care team. Members can upload past labs, share their health history, and get personalized insights to help them achieve their health goals. Testing is available at over 2,000 Quest Diagnostics locations nationwide, or via at-home blood draw for an additional fee. Baseline biomarker retests and additional specialty diagnostic tests are also available to members at preferred pricing.

[2] “We built Superpower to move healthcare from reactive to proactive – but proactive only works when testing leads to action, and action leads back to testing,” said Max Marchione, Co-Founder and CEO of Superpower. “That feedback loop has never existed in consumer health until now. IM8 gives our members a supplement protocol we can stand behind with full confidence — clinical-grade formulations built for the same standard of evidence our platform is built on. This is what the future of health looks like: data in, protocol out, results measured.”

IM8 ships to 31 countries and counts tennis world number one Aryna Sabalenka and Formula 1 driver Ollie Bearman among its brand ambassadors. Superpower’s investors include NBA champion Giannis Antetokounmpo and the Winklevoss twins, and the platform has built the infrastructure to make preventive blood testing as routine and affordable as a gym membership.

The integrated offering is available now. To learn more, IM8 customers can access Superpower membership pricing at im8health.com, and Superpower members can explore IM8’s product range at superpower.com.

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 31 countries worldwide.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.

About Superpower

Superpower is a new kind of health membership – built on comprehensive lab work, not guesswork. For $199 per year, members get annual blood testing across 100+ biomarkers, an AI health layer grounded in their real data, personalized health protocols, and 24/7 concierge care. Founded by Max Marchione and Jacob Peters, Superpower has raised over $40 million in funding with its Series A led by Forerunner Ventures. Superpower is accessible at over 2,000 Quest Diagnostics locations across the US, with at-home blood draws also available. To learn more about Superpower, please visit superpower.com.

Investor Relations Contact:
[email protected]
[email protected]

Angela Cheung
Investor Relations / Corporate Finance
[email protected]